<DOC>
	<DOCNO>NCT00202540</DOCNO>
	<brief_summary>The purpose study demonstrate long term efficacy S18986 versus placebo episodic memory performance patient MCI</brief_summary>
	<brief_title>Efficacy Safety S18986 Treatment Mild Cognitive Impairment Patients</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Memory complaint Acetylcholinesterase inhibitor stop least 3 month selection Dementia Parkinson 's disease Vascular disorder Depression Epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>